Latent View (LATENTVIEW)
Fast GrowerFairStock Score: 63/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹285.2 |
| Market Cap | ₹5,901.5 Cr |
| P/E Ratio | 30.21 |
| ROCE | 15.22% |
| ROE | 13.26% |
| Dividend Yield | 0% |
| Profit Growth | -5.3% |
| Debt/Equity | 0.02 |
| Sales Growth | 21.5% |
| Free Cash Flow | ₹-90.85 Cr |
| Promoter Holding | 65.1% |
| 52-Week Range | ₹248 — ₹517.5 |
| Sector | IT - Software |
| Book Value | ₹84.82 |
Strengths
- Sales and profit growth are strong at 21.72% and 23.81%, with latest quarter sales of ₹278 Cr and net profit of ₹51 Cr.
- Very low leverage (debt/equity 0.02) and Altman Z-Score 4.14 indicate solid financial health.
- Piotroski F-Score of 8/9 signals good fundamental strength across profitability, leverage, and efficiency.
- Promoter holding of 65.10% aligns management incentives with minority shareholders.
Concerns
- At ₹298.70, the stock trades at P/E 35.09 and P/B 4.12, far above Graham Number ₹126.04, leaving no margin of safety.
- Free cash flow is –₹91 Cr despite reported profits; earnings quality needs close scrutiny.
- ROE of 13.26% and ROCE of 15.22% are only moderate for a growth premium; zero dividend adds pressure on capital allocation.
AI Analysis
Latent View comes across as an interesting fast grower, not a classic Graham bargain. The numbers show a clean balance sheet: debt/equity 0.02, Altman Z-Score 4.14, and a Piotroski F-Score of 8 out of 9. The FairStock Score of 63/100 calls it steady. That is the sort of financial health I like to see. Sales grew 21.72% and profit grew 23.81%, and the latest quarter shows ₹278 Cr sales with ₹51 Cr net profit. Promoters hold 65.10%, so their interests are aligned with minority holders. But my discipline is price versus value. At ₹298.70, the market cap is ₹6,978 Cr, which works out to a P/E of 35.09 and a P/B of 4.12. A 13.26% ROE and 15.22% ROCE are respectable, but not so extraordinary that they justify such a premium unless the company can keep compounding at 20%+ for years. The Graham Number is only ₹126.04; trading at more than double that gives me a negative margin of safety. There is also a glaring red flag: free cash flow is –₹91 Cr despite strong reported profits. In my experience, earnings without cash are suspect. The zero dividend is acceptable only if retained capital earns high returns; a 13% ROE does not fully convince me. The 52-week range, ₹248.00 to ₹517.50, shows how quickly sentiment can change. This is a fast grower, and maybe a good one, but I cannot call it a value investment at today's price. I would keep it on my watchlist and wait for either a lower price or clear evidence that cash conversion improves.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer